Actinium Pharmaceuticals, Inc.
$1.01
+0.01 (+1.00%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +20.7%
- 3 Months
- -19.8%
- YTD
- -25.7%
- 1 Year
- -42.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 65.5%
- Largest decline max drawdown, since Aug 2025
- -58.2%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.53
Own ATNM?
See how ATNM contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.